Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards...

Astra Zeneca pausar test av covid-vaccin

Skälet till att företaget tillfälligt stoppar sina kliniska prövningar med vaccinet är att en studiedeltagare fått en sjukdom och det ska utredas om det finns n...

Rätt inställd hörapparat kan minska tinnitusbesvär

Enligt en studie från Lunds universitet kan en enkel undersökning och rätt inställning av hörapparater minska tinnitusbesvär.

“Photon counting in computed tomography is the holy grail”

Erik Fredenberg, a researcher in physics at KTH and GE, is working to implement photon-counting CT in clinics. To shorten lead times and reduce the radiation do...

Before you choose a CRO

– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of De...

Krönika: Collaboration across borders

The government proposes fines for pharmaceutical companies that fail to notify drug shortages in time

According to a compilation from the Swedish Medicines Agency, the number of residually notified medicines increased by 54 % in Sweden last year compared to the ...

Ny definition av smärta välkomnas

Den nya definitionen kan enligt en smärtläkare bidra till att patienter slipper mötas av okunniga utlåtanden.

Neanderthal genes and Nobel Prize in a popular lecture at Bioscience

An inherited gene variant from our ”evolutionary cousins” – the extinct Neanderthals – may affect how our bodies break down certain drugs. “It’s only a matter o...

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

How to become globally competitive

Here Gunilla Osswald from BioArctic share her experience of scaling up and be competative on the global arena.

Drug development creates new challenges for regulators

Lucy Robertshaw: There is a bio revolution happening right now

Lucy Robertshaw is both proud and excited to be taking the baton of moderating this year’s Pharma Outsourcing event.

Marie Gårdmark: Do EMA and FDA talk to each other?

Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.

"Unclear proposal from the EU Commission on how to solve the MDR challenges"

Even before the EU regulation on medical devices (MDR) came into force, medical technology companies and doctors were concerned that it would endanger the avail...

Ny modell ger ytterligare stöd för munskydd: ”Ger ett utmärkt skydd”

Forskare vid bland annat Chalmers har tagit fram en modell för att mäta hur virus färdas genom luften – och hur effektivt munskydd är för att hindra smittspridn...

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

It´s time to establish relations

Communication with the patient is the key to future healthcare, writes Hanna Brodda, editor in chief of Life Science Sweden.

Lockdown-studie kritiseras även i USA

I USA har den uppmärksammade metastudie som uppger att knappt några liv har räddats med hjälp av lockdowns blivit kraftigt ifrågasatt av forskare.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Här är virusvarianterna du ska ha koll på

Glöm den brittiska, sydafrikanska och indiska varianten. Efter att flera länder klagat beslutade WHO om nya namn på olika muterade coronavirus.

Pharma Outsourcing igång på Stockholm Waterfront

With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

Astra Zeneca och Gilead kan gå samman

De två läkemedelsjättarna är i samtal om en sammanslagning, enligt källor till Bloomberg.